Navigation Links
ETEX Corporation Announces Distribution Agreement With Stryker
Date:7/14/2010

CAMBRIDGE, Mass., July 14 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, announced today that it has entered into a non-exclusive distribution agreement with Stryker's Spine division to market and sell the privately labeled Bio MatrX Structure and Bio MatrX Generate bone graft substitute products. Both products utilize ETEX's proprietary nanocrystalline calcium phosphate technology, which is wholly owned, developed and exclusively manufactured by ETEX Corporation.

(Logo:  http://photos.prnewswire.com/prnh/20080424/NETH117LOGO  )

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080424/NETH117LOGO )

BIO MatrX Structure is a highly porous, synthetic bone graft substitute that sets hard upon implantation for a complete defect fill. The resulting osteoconductive scaffold provides interconnected porosity and high surface area to facilitate cell mediated remodeling and new bone growth.

BIO MatrX Generate is a combination of ETEX's osteoconductive nanocrystalline calcium phosphate and Demineralized Bone Matrix (DBM) which is tested for osteoinductive potential by lot, after sterilization, in an in vivo athymic nude rodent muscle pouch model. The viscous putty sets hard after closure providing an osteoconductive scaffold to facilitate new bone growth.

Both materials are FDA cleared to be hydrated with saline or blood; and are indicated as bone void fillers of the pelvis, extremities and the posterolateral spine.

Brian Ennis, President and CEO of ETEX Corporation, comments: "ETEX Corporation is highly selective and discriminating in securing strategic partners. Stryker's Spine division possesses the desired distribution and marketing capabilities to increase exposure for ETEX's existing products and emerging technologies. The dynamic expansion of our distribution network is a direct reflection of the increasing market interest in our rapidly expanding product portfolio. We are pleased that Stryker has selected ETEX as its partner to complement their product offerings in the orthobiologic market segment."

About ETEX Corporation

Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems. For more information, visit www.etexcorp.com.


'/>"/>
SOURCE ETEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
2. Pharmos Corporation Reports 2008 Second Quarter Results
3. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
4. Genaera Corporation Announces Second Quarter Financial Results
5. MannKind Corporation Reports Second Quarter Financial Results
6. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
7. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
10. Mymetics Corporation Important Shareholders Information Conference Call
11. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)...  BioTech Holdings announced today identification and patenting ... stem cell therapy prevents limb loss in animal ... that treatment with ProCell resulted in more than ... to standard bone marrow stem cell administration.  Interestingly, ... of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree Wellness ... targeting the needs of consumers who are incorporating medical marijuana into their wellness ... Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s two ...
(Date:10/7/2017)... (PRWEB) , ... October 06, ... ... leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, ... Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
Breaking Biology News(10 mins):